Cancer Diagnostics – Products

This compendium provides researchers with a portfolio of electrophoresis instruments to support quality control and automation for a more reliable NGS workflow.

Ultima Genomics has launched the "Count on Us" initiative, offering 3 trillion DNA sequencing reads to researchers at academic, public or non-profit institutions in the U.S. and Canada.

This application note explores how electrophoretic methods surpass the capabilities of traditional methods to accurately distinguish between cfDNA and contaminating high molecular weight (HMW) DNA, making them ideal for cfDNA quality control.

Zymo Research celebrates a legal victory as the court denies QIAGEN’s motion in an ongoing antitrust and patent dispute.

Labor Dr. Wisplinghoff, and Genomic Testing Cooperative (GTC), are excited to announce the launch of their collaboration.

This application note provides data-driven insights for optimizing cfDNA workflows, from initial sample input to final sequencing parameters.

Build your own instrument – fully automated cell imaging and picking. Use the instrument configurator to design your very own customized CellCelector, perfectly tailored to meet your unique needs.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced updates on its oncology assay portfolio and regulatory milestones, ahead of its presence at the AMP 2024 meeting.

Informed Genomics, the UK-based genomic testing laboratory delivering innovative ISO accredited services, has been selected by EMQN CIC to provide tumour profiling to support its quality assurance services.

Zymo Research Corporation acknowledges the patent infringement lawsuit filed by Qiagen GmbH on August 20, 2024, at the US District Court for the Central District of California regarding its MAGicBead cfDNA isolation technology.